Key facts
| Price (PPV) | 285 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | ivabradine |
| Class | Cardiac therapy |
| ATC code | C01EB17 |
| Manufacturer | ZENITH PHARMA |
| Presentation | Boite de 56 |
| Hospital price | 189.60 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement symptomatique de l’angor stable chronique L’ivabradine est indiquée dans le traitement symptomatique de l’angor stable chronique chez l’adulte coronarien en rythme sinusal ayant une fréquence cardiaque supérieure ou égale à 70 bpm. L’ivabradine est indiquée : - Chez les adultes présentant une intolérance ou une contre-indication aux bêta-bloquants, - ou en association aux bêta-bloquants chez des patients insuffisamment contrôlés par une dose optimale de bêta-bloquants. Traitement de l’insuffisance cardiaque chronique L’ivabradine est indiquée dans le traitement de l’insuffisance cardiaque chronique de classe NYHA II à IV avec dysfonction systolique, chez les patients en rythme sinusal et dont la fréquence cardiaque est supérieure ou égale à 75 bpm, en association au traitement standard comprenant les bêta-bloquants, ou en cas de contre-indication ou d’intolérance aux bêta-bloquants.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Ivaral 7.5 mg (ZENITH PHARMA) contains the same active substance as Ivaral 7.5 mg (Ivabradine) at the same strength, but in a different pack: Boite de 28 at 169.80 MAD, i.e. 6.06 MAD per unit against 5.09 MAD for Ivaral 7.5 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Coralan 7.5 mg | SERVIER MAROC | Boîte de 56 | 344 MAD | 6.14 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Ivaral 7.5 mg | ZENITH PHARMA | Boite de 28 | 169.80 MAD | 6.06 / unit |
| Coralan 7.5 mg | SERVIER MAROC | Boîte de 28 | 205 MAD | 7.32 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Ivaral 7.5 mg
Ivaral 7.5 mg belongs to the cardiac therapy therapeutic class. In Morocco, this drug is marketed by ZENITH PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Ivaral 7.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Ivaral 7.5 mg
Answers to common questions from Moroccan patients about this drug.